Table 2.
Ratings of background and outcome variables in patient participants before and after PCPC implementation
| Pre-implementation participants (n = 50)a | Post-implementation participants (n = 50) | Two-tailed t (p) | 95% CI of mean difference | |
|---|---|---|---|---|
| Measure | M (SD) | M (SD) | ||
| Background variables | ||||
| EQ-5D Index | .62 (.38) | -.05 (.31) | 9.56 (<.0005) | .53–.81 |
| EQ-5D VAS | 65.99 (25.04) | 52.76 (24.47) | 2.67 (.009) | 3.40–23.06 |
| GAF Function subscale | 67.06 (15.12) | 55.22 (13.60) | 4.08 (<.0005) | 6.08–17.60 |
| GAF Symptom subscale | 60.24 (15.78) | 48.86 (15.13) | 3.67 (<.0005) | 5.22–17.55 |
| PANSS RSS | 14.67 (5.56) | 13.10 (4.19) | 1.58 (.117) | -.40–3.53 |
| Outcome variables | ||||
| Empowerment Scale | 2.95 (.29) | 2.91 (.29) | ||
| UKU ConSat Scale | 7.11 (12.44) | 9.06 (13.15) | ||
aDue to missing data in the pre-intervention sample, GAF Function subscale has n = 48, GAF Symptom subscale n = 49, PANSS RSS n = 48 and Empowerment Scale n = 49